Portage Biotech soars on potential deal with Immunova

Alpha Compute

17/12/2024 13:58

** Shares of drug developer Portage Biotech Inc  PRTG.O 
rise 187% at $9.09 premarket
    ** PRTG says that it has signed a letter of intent with
Immunova for an option agreement to acquire its wholly owned
subsidiary, iOx Therapeutics
    ** iOx Therapeutics focuses on developing immunotherapies -
PRTG
    ** As of last close, stock has fallen ~91% YTD

 (Reporting by Kamal Choudhury in Bengaluru)
 ((Kamal.Choudhury@thomsonreuters.com;))